Together we deliver life-saving therapies to patients in need. With the commitment and drive you bring to the workplace every day, you will be part of a team that is changing the world and helping millions of people live healthier, more fulfilling lives. Our worldwide staff of more than 9,000 people is a close community where you can see the tangible results of your contributions, where every individual matters, and everyone has a chance to enhance their skills through ongoing development. Our scientific focus has resulted in 23 marketed products that are benefiting millions of people, a pipeline of late-stage drug candidates and unmatched patient access programs to ensure medications are available to those who could otherwise not afford them. Today, Gilead's research and development effort is the largest it has ever been evaluating compounds with the potential to become the next generation of innovative therapies for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. The commercial success of Gilead's portfolio of 23 products has provided the company with the vital resources to support the development of new therapeutic advancements. Working at Gilead provides you with plenty of opportunities for career advancement in a growing and agile environment while working with highly respected teams. We would like to invite you to be a part of an organization that has helped millions of people around the world live healthier and more fulfilling lives. www.gilead.com/careers
33
Total Investments
28
Portfolio Companies
-
Exits
7
Industries
General Information
Industries
Big Data, Biopharma +5
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Gilead Sciences
Recent Investments (33)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Post Ipo Equity | •••••• | May 2026 | |
| Acquisition | •••••• | Apr 2026 | |
| Acquisition | •••••• | Feb 2026 | |
| Seed | •••••• | Oct 2025 | |
| Late Vc | •••••• | Sep 2025 | |
|
|
Post Ipo Equity | •••••• | Dec 2024 |
|
|
Post-IPO Equity | •••••• | Apr 2024 |
|
|
Acquisition | •••••• | Feb 2024 |
|
|
Post Ipo Equity | •••••• | Jan 2024 |
|
|
Post Ipo Equity | •••••• | Oct 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.